$2.49T
Total marketcap
$66.26B
Total volume
BTC 50.20%     ETH 16.10%
Dominance

EirGenix Inc. 6589.TWO Stock

82.6 TWD {{ price }} -3.169019% {{change_pct}}%
COUNTRY
Taiwan
Market Cap
25.28B TWD
LOW - HIGH [24H]
82.2 - 85.3 TWD
VOLUME [24H]
905.59K TWD
{{ volume }}
P/E Ratio
0
Earnings per share
-3 TWD

EirGenix Inc. Price Chart

EirGenix Inc. 6589.TWO Financial and Trading Overview

EirGenix Inc. stock price 82.6 TWD
Previous Close 108.5 TWD
Open 109 TWD
Bid 109.5 TWD x N/A
Ask 110 TWD x N/A
Day's Range 109 - 111 TWD
52 Week Range 78 - 163.5 TWD
Volume 1.09M TWD
Avg. Volume 3.37M TWD
Market Cap 33.34B TWD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -3 TWD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 172 TWD

6589.TWO Valuation Measures

Enterprise Value 33.02B TWD
Trailing P/E N/A
Forward P/E 24.013159
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 3.1194804
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

EirGenix Inc. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 19.88%
S&P500 52-Week Change 20.43%
52 Week High 163.5 TWD
52 Week Low 78 TWD
50-Day Moving Average 113.86 TWD
200-Day Moving Average 117.11 TWD

6589.TWO Share Statistics

Avg. Volume (3 month) 3.37M TWD
Avg. Daily Volume (10-Days) 1.19M TWD
Shares Outstanding 304.49M
Float N/A
Short Ratio N/A
% Held by Insiders 33.39%
% Held by Institutions 14.93%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) 4.88 TWD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 756.45M TWD
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -1.1
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 35.102

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of EirGenix Inc.

Country Taiwan
State N/A
City New Taipei City
Address No. 101, Kangning Street
ZIP N/A
Phone 886 2 7708 0123
Website https://www.eirgenix.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical, quality control, cGMP manufacturing mammalian system and microbial system, and antibody-drug conjugate services. It also provides covid-19 antigen rapid test and CRM197 carrier protein related products. The company was incorporated in 2012 and is based in New Taipei City, Taiwan.

Q&A For EirGenix Inc. Stock

What is a current 6589.TWO stock price?

EirGenix Inc. 6589.TWO stock price today per share is 82.6 TWD.

How to purchase EirGenix Inc. stock?

You can buy 6589.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for EirGenix Inc.?

The stock symbol or ticker of EirGenix Inc. is 6589.TWO.

Which industry does the EirGenix Inc. company belong to?

The EirGenix Inc. industry is Biotechnology.

How many shares does EirGenix Inc. have in circulation?

The max supply of EirGenix Inc. shares is 306.05M.

What is EirGenix Inc. Price to Earnings Ratio (PE Ratio)?

EirGenix Inc. PE Ratio is now.

What was EirGenix Inc. earnings per share over the trailing 12 months (TTM)?

EirGenix Inc. EPS is -3 TWD over the trailing 12 months.

Which sector does the EirGenix Inc. company belong to?

The EirGenix Inc. sector is Healthcare.